MedTrace Logo

A Comparative Study on Local Allergic Responses of Bee Venom and Essential Bee Venom Pharmacopuncture

NCT02364349 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-11-07

No results posted yet for this study

Summary

This double-blinded randomized clinical trial investigates any differences in allergic responses elicited by Bee Venom (BV) and Essential Bee Venom (eBV).

Conditions

  • Healthy Volunteers

Interventions

DRUG

Bee Venom (BV)

Raw Bee Venom

DRUG

Essential Bee Venom (e-BV)

Bee venom without Hyaluronidase, Lysophospholipase, α-D-glucosidase, PLA2, Adolapin

Sponsors & Collaborators

  • Jaseng Hospital of Korean Medicine

    lead OTHER

Principal Investigators

  • Joon-Shik SHIN, MD · Jaseng Hospital of Korean Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02364349 on ClinicalTrials.gov